中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

11 records (took 0.021 seconds)

    Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereof
    1.
    发明授权
    Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereof 有权

    公开(公告)号：US10428149B2

    公开(公告)日：2019-10-01

    申请号：US15558372

    申请日：2016-03-18

    Applicant: UNIVERSITÄT STUTTGART ,  BIONTECH AG

    Inventor： Ugur Sahin ,  Roland Kontermann ,  Klaus Pfizenmaier ,  Martin Siegemund ,  Meike Hutt ,  Oliver Seifert

    IPC: C07K16/32 ,  C07K16/28 ,  C07K14/705

    Abstract: The present invention relates to a polypeptide comprising a component A with at least three tumor necrosis factor (TNF) homology domains of TNF-ligand family members (THD) in which C-terminal and N-terminal reference points are defined by consensus sequences and which are connected through short stretches of additional C-terminal and/or N-terminal amino acids of the THD or variants thereof, and a component B comprising a dimerization domain. Further, the present invention relates to a polypeptide comprising at least three THDs in which C-terminal and N-terminal reference points are defined by consensus sequences and which are connected through short stretches of additional C-terminal and/or N-terminal amino acids of the THD or variants thereof. Further, the invention relates to a nucleic acid comprising said polypeptides, a vector comprising said nucleic acid and a pharmaceutical composition comprising said polypeptides, or said nucleic acids or said vector. Further, the present invention relates to said polypeptides, said nucleic acid or said vector for the use as a medicament or for the use in the diagnosis, prophylaxis or treatment of hyperproliferative disorders and inflammatory disorders.

    Antigen binding protein against HER3
    9.
    发明授权
    Antigen binding protein against HER3 有权

    公开(公告)号：US11008402B2

    公开(公告)日：2021-05-18

    申请号：US16326864

    申请日：2017-09-15

    Applicant: UNIVERSITÄT STUTTGART

    Inventor： Roland Kontermann ,  Lisa Schmitt ,  Meike Hutt ,  Oliver Seifert ,  Monilola Olayioye ,  Michael Hust ,  Stefan Dübel ,  Jonas Zantow

    IPC: A61K39/00 ,  C07K16/32 ,  C07K16/28 ,  C07K16/30 ,  A61P35/00 ,  A61K39/395

    Abstract: The invention provides an antigen-binding protein that specifically binds to a conformational epitope formed by domain III & IV of human epidermal growth factor receptor 3 (HER3) and antigen-binding proteins which compete therewith for binding, as well as fusion protein or conjugate comprising these. The invention also provides nucleic acid molecule comprising a sequence encoding said antigen binding proteins, vectors comprising the nucleic acid, and cells and pharmaceuticals comprising the antigen binding protein, the fusion protein, the nucleic acid, or the vector. The invention also provides the antigen binding protein, the fusion protein or conjugate, the nucleic acid, the vector, the cell, or the pharmaceutical for use as a medicament. The invention further provides a method of inhibiting tumor growth or treating cancer, comprising administering a therapeutically effective amount of the antigen binding protein, the fusion protein or conjugate, the nucleic acid, the vector, the cell, or the pharmaceutical.

Patent Agency Ranking